Nabriva Therapeutics Us, Inc
XENLETA
Manufacturer:
Nabriva Therapeutics Us, Inc
Name:
XENLETA
HCPCS Code Descriptor:
Injection, lefamulin, 1 mg
Category:
J Code
HCPCS:
J0691
NDC(s):
72000-0120-06
Primary Type:
Antibiotic
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
XENLETA is an Antibiotic drug manufactured by Nabriva Therapeutics Us, Inc and administered via the Intravenous route of administration. The J Code: J0691 is aligned to the drug XENLETA.